世界科学技术-中医药现代化
世界科學技術-中醫藥現代化
세계과학기술-중의약현대화
World Science and Technology-Modernization of Traditional Chinese Medicine
2015年
9期
1899-1905
,共7页
孙萍萍%张天娇%许可嘉%张玮%李健%刘连起
孫萍萍%張天嬌%許可嘉%張瑋%李健%劉連起
손평평%장천교%허가가%장위%리건%류련기
雷公藤%毒性%不良反应事件%雷公藤多苷%随机对照
雷公籐%毒性%不良反應事件%雷公籐多苷%隨機對照
뢰공등%독성%불량반응사건%뢰공등다감%수궤대조
Tripterygium Wilfordii%toxicity%adverse event%tripterygium glycosides%RCT
目的:本研究旨在尽量如实概括总结雷公藤及其制剂毒性引起的不良反应事件(Adverse Drug Reaction,ADR)情况,反映影响雷公藤毒性的各因素与报道出的ADR之间可能存在的关系。方法:系统检索Pubmed、中国知网、万方数据库、维普数据库和中国生物医学期刊数据库等5个数据库建库至2014年2月25日的雷公藤及其制剂毒性的所有相关文献,然后对其中的随机对照试验进行系统归纳、分析和总结。结果:纳入260篇随机对照试验,13301例患者。分组分类统计结果显示,RCT1组和RCT2组的消化系统、生殖系统等的ADR发生率不同,RCT1和RCT2组的消化系统ADR发生率(每百人)为14.73和12.26,生殖系统为8.25和8.00,肝脏为6.50和5.66,肾脏为6.79和3.03,血液系统为6.73和6.50,心血管系统为2.35和0.67,皮肤粘膜系统为11.42和4.78。RCT1组和RCT2组治疗类风湿关节炎的文献都是最多,分别占22.17%和63.16%,ADR发生率为34.18和27.26。RCT1组RA、IgA肾病、肾炎、肾病综合征、糖尿病肾病、银屑病、藓疹和子宫肌瘤等7类疾病对应的ADR发生率的标准差为8.69,RCT2组RA、IgA肾病、银屑病和藓疹对应的ADR发生率的标准差为7.11。结论:临床使用雷公藤及其制剂可能引起的ADR分布为:消化系统、生殖系统和肝脏的ADR发生率最高,不同疾病(如类风湿关节炎、肾炎、肾病综合征等)对应的ADR发生率差异很大。因此,建议患者在使用雷公藤及其制剂时,选择合适的雷公藤制剂,做好护胃、护肝等措施;服用过程中注意患者的反应,适可而止,最大限度的避免可能产生的ADR。
目的:本研究旨在儘量如實概括總結雷公籐及其製劑毒性引起的不良反應事件(Adverse Drug Reaction,ADR)情況,反映影響雷公籐毒性的各因素與報道齣的ADR之間可能存在的關繫。方法:繫統檢索Pubmed、中國知網、萬方數據庫、維普數據庫和中國生物醫學期刊數據庫等5箇數據庫建庫至2014年2月25日的雷公籐及其製劑毒性的所有相關文獻,然後對其中的隨機對照試驗進行繫統歸納、分析和總結。結果:納入260篇隨機對照試驗,13301例患者。分組分類統計結果顯示,RCT1組和RCT2組的消化繫統、生殖繫統等的ADR髮生率不同,RCT1和RCT2組的消化繫統ADR髮生率(每百人)為14.73和12.26,生殖繫統為8.25和8.00,肝髒為6.50和5.66,腎髒為6.79和3.03,血液繫統為6.73和6.50,心血管繫統為2.35和0.67,皮膚粘膜繫統為11.42和4.78。RCT1組和RCT2組治療類風濕關節炎的文獻都是最多,分彆佔22.17%和63.16%,ADR髮生率為34.18和27.26。RCT1組RA、IgA腎病、腎炎、腎病綜閤徵、糖尿病腎病、銀屑病、蘚疹和子宮肌瘤等7類疾病對應的ADR髮生率的標準差為8.69,RCT2組RA、IgA腎病、銀屑病和蘚疹對應的ADR髮生率的標準差為7.11。結論:臨床使用雷公籐及其製劑可能引起的ADR分佈為:消化繫統、生殖繫統和肝髒的ADR髮生率最高,不同疾病(如類風濕關節炎、腎炎、腎病綜閤徵等)對應的ADR髮生率差異很大。因此,建議患者在使用雷公籐及其製劑時,選擇閤適的雷公籐製劑,做好護胃、護肝等措施;服用過程中註意患者的反應,適可而止,最大限度的避免可能產生的ADR。
목적:본연구지재진량여실개괄총결뢰공등급기제제독성인기적불량반응사건(Adverse Drug Reaction,ADR)정황,반영영향뢰공등독성적각인소여보도출적ADR지간가능존재적관계。방법:계통검색Pubmed、중국지망、만방수거고、유보수거고화중국생물의학기간수거고등5개수거고건고지2014년2월25일적뢰공등급기제제독성적소유상관문헌,연후대기중적수궤대조시험진행계통귀납、분석화총결。결과:납입260편수궤대조시험,13301례환자。분조분류통계결과현시,RCT1조화RCT2조적소화계통、생식계통등적ADR발생솔불동,RCT1화RCT2조적소화계통ADR발생솔(매백인)위14.73화12.26,생식계통위8.25화8.00,간장위6.50화5.66,신장위6.79화3.03,혈액계통위6.73화6.50,심혈관계통위2.35화0.67,피부점막계통위11.42화4.78。RCT1조화RCT2조치료류풍습관절염적문헌도시최다,분별점22.17%화63.16%,ADR발생솔위34.18화27.26。RCT1조RA、IgA신병、신염、신병종합정、당뇨병신병、은설병、선진화자궁기류등7류질병대응적ADR발생솔적표준차위8.69,RCT2조RA、IgA신병、은설병화선진대응적ADR발생솔적표준차위7.11。결론:림상사용뢰공등급기제제가능인기적ADR분포위:소화계통、생식계통화간장적ADR발생솔최고,불동질병(여류풍습관절염、신염、신병종합정등)대응적ADR발생솔차이흔대。인차,건의환자재사용뢰공등급기제제시,선택합괄적뢰공등제제,주호호위、호간등조시;복용과정중주의환자적반응,괄가이지,최대한도적피면가능산생적ADR。
This study was aimed to summarize the adverse drug reaction (ADR) caused by the toxicity of Tripterygium Wilfordiiand its preparations, in order to explore possible relationship betweenTripterygium Wilfordiifactors and reported ADR. Relevant articles on toxicity ofTripterygium Wilfordiiand its preparations were systematically searched in 5 databases, including the Pubmed, CNKI,Wanfang Data, VIP Data and Sinomed from the database was established until Feb 25th, 2014. And then, the randomized controlled trials (RCTs) were systematically collected, analyzed and summarized. The results showed that there were 260 RCTs with 13301 patients included. The outcome of data analysis showed that ADR rates of digestive system and reproductive system of RCT1 and RCT2 were different. ADR rates (per hundred people) in RCT1 and RCT2 were as follows: digestive system were 14.73 and 12.26, reproductive system were 8.25 and 8.00, liver was 6.50 and 5.66, kidneys were 6.79 and 3.03, blood system were 6.73 and 6.50, cardiovascular system were 2.35 and 0.67, skin and mucous system were 11.42 and 4.78, respectively. Articles on rheumatoid arthritis (RA) of both RCT1 and RCT2 were the highest, which occupied 22.17% in RCT1 and 63.16% in RCT2. The corresponding ADR rates were 34.18 and 27.26. The standard deviation (SD) of 7 disease types, which were RA, IgA nephropathy, nephritis, nephrotic syndrome (NS), diabetic nephropathy, psoriasis, lichen and rashes, as well as uterine fibroids, was 8.69 in RCT1. The SD of RA, IgA nephropathy, psoriasis, lichen and rashes was 7.11 in RCT2. It was concluded that the possible ADR distribution ofTripterygium Wilfordiiand its preparations were the highest in the digestive system, reproductive system and liver. Besides, different diseases (i.e., RA, nephritis, NS, and etc.) had huge differences with their correspondent ADR rates. Therefore, it was suggested that specific measures should be taken to select the appropriateTripterygium Wilfordiipreparation, protect the stomach and liver during the application ofTripterygium Wilfordiiand its preparations. During medication, attentions should be paid to the reaction of patients. Stop the medication when necessary to minimize ADR rates to the lowest.